Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXELIXIS, INC. Director's Dealing 2017

Mar 8, 2017

30561_dirs_2017-03-07_3ea5e4bb-a7d9-4357-bdbc-cce9a65dbd75.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2017-03-03

Reporting Person: Hessekiel Jeffrey (EVP and General Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-03-03 Common Stock M 100000 $7.27 Acquired 346617 Direct
2017-03-03 Common Stock S 36999 $23 Disposed 309618 Direct
2017-03-03 Common Stock S 3519 $23.20 Disposed 306099 Direct
2017-03-03 Common Stock S 59482 $23.05 Disposed 246617 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-03-03 Option (right to buy) $7.27 M 100000 Disposed 2021-02-09 Common Stock (100000.0) Direct

Footnotes

F1: Includes 16,250 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

F2: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $23.03 to $23.14. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.

F3: The option, representing the right to purchase a total of 230,000 shares of Exelixis, Inc. common stock, was exercisable as to 172,500 shares on the Transaction Date. The remainder of the option will vest as to 1/48th of the original number of shares subject to the option on each monthly anniversary of the February 10, 2014 grant date.